Free Trial

Green Thumb Industries (OTCMKTS:GTBIF) Trading Up 5.5% - What's Next?

Green Thumb Industries logo with Medical background

Key Points

  • Green Thumb Industries Inc. shares rose by 5.5% to $8.56, despite a significant decline in trading volume, which was 82% lower than average.
  • Analysts have given the company a consensus rating of "Buy", with Benchmark reaffirming a buy rating and Zacks upgrading from a "strong sell" to a "hold".
  • The company reported a loss of $0.01 earnings per share for the last quarter, missing estimates, while revenue reached $293.26 million, exceeding expectations.
  • MarketBeat previews top five stocks to own in October.

Shares of Green Thumb Industries Inc. (OTCMKTS:GTBIF - Get Free Report) were up 5.5% during trading on Tuesday . The stock traded as high as $8.58 and last traded at $8.56. Approximately 91,140 shares changed hands during trading, a decline of 82% from the average daily volume of 501,819 shares. The stock had previously closed at $8.11.

Analysts Set New Price Targets

GTBIF has been the subject of several recent analyst reports. Benchmark reaffirmed a "buy" rating on shares of Green Thumb Industries in a report on Monday, August 11th. Zacks Research raised Green Thumb Industries from a "strong sell" rating to a "hold" rating in a research note on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Buy".

Get Our Latest Report on GTBIF

Green Thumb Industries Trading Up 6.3%

The stock has a market cap of $1.82 billion, a PE ratio of 78.37 and a beta of 1.22. The business's 50-day moving average price is $7.08 and its 200-day moving average price is $6.18.

Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). Green Thumb Industries had a return on equity of 1.62% and a net margin of 2.51%.The company had revenue of $293.26 million during the quarter, compared to analysts' expectations of $280.66 million. As a group, analysts predict that Green Thumb Industries Inc. will post 0.32 earnings per share for the current year.

Green Thumb Industries Company Profile

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Green Thumb Industries Right Now?

Before you consider Green Thumb Industries, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.

While Green Thumb Industries currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.